# Feasibility Study on LITT for Newly Diagnosed Glioblastoma

> **NCT02880410** · PHASE1 · TERMINATED · sponsor: **Monteris Medical** · enrollment: 3 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DEVICE:** NeuroBlate System
- **DRUG:** Radiation therapy and temozolomide

## Key facts

- **NCT ID:** NCT02880410
- **Lead sponsor:** Monteris Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-08-15
- **Primary completion:** 2018-09-14
- **Final completion:** 2018-09-14
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Terminated (failure to enroll)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02880410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02880410, "Feasibility Study on LITT for Newly Diagnosed Glioblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02880410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*